Geode Capital Management LLC recently announced the acquisition of new stake in Novo Integrated Sciences Inc. (NASDAQ:NVOS). The institutional investor has increased its shareholding in the Healthcare company by 2,942.02% to 0.82 million shares with purchase of 0.79 million shares. This fresh investment now brings its stake to 0.55% valued currently at $0.11 million. In addition, SSgA Funds Management, Inc. raised its holdings by 0.27 million to 0.29 million shares.
With over 29.37 million Novo Integrated Sciences Inc. (NVOS) shares trading Friday and a closing price of $0.40 on the day, the dollar volume was approximately $11.75 million. The shares have shown a positive half year performance of 246.32% and its price on 09/15/23 lost nearly -6.10%. Currently, there are 157.59M common shares owned by the public and among those 144.38M shares have been available to trade.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Novo Integrated Sciences Inc. are Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Fidelity Series Total Market Inde. Vanguard Extended Market Index Fu owns 1.26 million shares of the company’s stock, all valued at over $0.18 million. Fidelity Series Total Market Inde bought 0.23 million shares to bring its total holdings to over 0.23 million shares at a value of $32274.0. Fidelity Series Total Market Inde now owns shares totaling to 0.16% of the shares outstanding.
Shares of Novo Integrated Sciences Inc. (NASDAQ: NVOS) opened at $0.359, down -$0.07 from a prior closing price of $0.43. However, the script later moved the day high at 0.4100, down -6.10%. The company’s stock has a 5-day price change of 49.53% and 197.40% over the past three months. NVOS shares are trading 98.91% year to date (YTD), with the 12-month market performance down to -61.11% lower. It has a 12-month low price of $0.07 and touched a high of $1.29 over the same period. NVOS has an average intraday trading volume of 42.93 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 68.57%, 144.36%, and 161.93% respectively.
Institutional ownership of Novo Integrated Sciences Inc. (NASDAQ: NVOS) shares accounts for 1.40% of the company’s 157.59M shares outstanding. Mutual fund holders own 0.15%, while other institutional holders and individual stakeholders account for 1.55% and -0.07% respectively.
It has a market capitalization of $57.44M and a beta (3y monthly) value of -0.34. The earnings-per-share (ttm) stands at -$0.95. Price movements for the stock have been influenced by the stock’s volatility, which stands at 37.52% over the week and 31.74% over the month.
